Jasper Therapeutics, Inc.JSPRNASDAQ
Loading
P/FCF Ratio Over TimeContracting
Percentile Rank20
Studio
Year-over-Year Change

Price to free cash flow ratio

Latest
-4.94
↓ 55% vs avg
Percentile
P20
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
-3.18
Historical baseline
PeriodValueYoY Change
2024-4.94-213.7%
2023-1.57-314.7%
2022-0.38+84.7%
2021-2.48-162.7%
2020-0.94+89.3%
2019-8.78-